Based on the prominent role of inflammation 28-30 in AF and recent insights into the anti-inflammatory effects, we hypothesized that the SCFA protects from NLRP3 signaling-mediated atrial remodeling in AF development. This evidence concerns the gene NLRP3 and atrial fibrillation.